A Tale Of 2 Markets

Mar. 21, 2013 11:01 AM ETBBBYQ, CAT, FDX, WSM5 Comments

Investors should be paying close attention to earnings reports and company guidance. They are pointing to a very bifurcated market. On one hand, any company that gets a good portion of its revenues overseas is disappointing investors right now. Two good examples of this are the reports yesterday from Federal Express (FDX) and Caterpillar (CAT).

Federal Express - The company reported earnings that after adjustments came in 15 cents a share less than expected. Federal Express's CEO stated the quarter was "very challenging" due to weakness in the global air freight business. It is also announced it was cutting some air cargo flights to Asia. The stock fell some $7 as a result. The shares still sell at some 16x this fiscal year's projected earnings and revenue growth will probably be around 5% for the near future so I would continue to avoid the shares until they get under $90 a share.

Caterpillar - The huge machinery manufacturer said its global retail machine sales fell 13% during a three-month period ended in February including a huge 26% drop in Asia-Pacific sales from the prior year. The stock fell 1.5% yesterday as result of the update even in an up market. The shares are cheap here at 10X trailing earnings. However, CAT just fell through its 200 day moving average. I would wait to buy or add to positions until it behaves better technically and/or improvement in international sales is evident.

European PMI figures came out today under expectations, even in Germany. It is obvious the situation in Europe is getting worse even as the continent works through its latest flare up (Cyprus). Continue to avoid companies who get a large portion of sales from Europe.

On the flip side to all this is companies that get all their revenues from

This article was written by

Bret Jensen profile picture
48.88K Followers

Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns.

Bret leads the investing group The Biotech Forum, in which he and his team offer a model portfolio with their favorite 12-20 high upside biotech stocks, live chat to discuss trade ideas, and weekly research and option trades. The group also provides market commentary and a portfolio update every weekend. Learn More.

Recommended For You

Related Stocks

SymbolLast Price% Chg
BBBYQ--
20230930-DK-Butterfly-1, Inc.
CAT--
Caterpillar Inc.
FDX--
FedEx Corporation
WSM--
Williams-Sonoma, Inc.

Related Analysis